Search - tctmd.com

Displaying 101 - 120 of 121

Sort: Relevancy | Date

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News HRS 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Todd Neale

May 18, 2018

News Conference News ISET 2018

Clinician-Patient Mismatch: How to Get Past the Imbalance in Knowledge (and Power)

Caitlin E. Cox

February 16, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Interrupting Anticoagulation? New Guidance Aims to Simplify Periprocedural Decision-Making

Todd Neale

January 09, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Conference News ESC 2016

New ESC A-fib Guidelines Call for Integrated Care for All Patients

Todd Neale

August 27, 2016

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Industry News

Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial

July 06, 2015

News Industry News

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

June 29, 2015

Presentation TCT 2013

Renal Nerve Ablation: Best of EHJ

Presenter: Ulf Landmesser

October 30, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

Advertisement

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

TCTMD’s Top 10 Most Popular Stories for May 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Clinician-Patient Mismatch: How to Get Past the Imbalance in Knowledge (and Power)

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Interrupting Anticoagulation? New Guidance Aims to Simplify Periprocedural Decision-Making

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

New ESC A-fib Guidelines Call for Integrated Care for All Patients

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

Renal Nerve Ablation: Best of EHJ

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Live Case Procedures Just as Safe as in Daily Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content